FBRX
Forte BiosciencesFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
FBRX vs peer average
29/100
FBRX vs. peer average (F vs. D)
Grade spread
A 1 · B 1 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
FULC is the first available peer comparator.
Another small-cap development-stage biotech where valuation depends heavily on pipeline credibility, trial timing, and financing access rather than current revenue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
FBRX
Forte Biosciences
FULC
Fulcrum Therapeutics
Grade
F
F
Momentum
5
5
Value
41
41
Sentiment
69
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs FULC
FBRX / FULC
Grade Position
Below peers
FBRX vs. peer average (F vs. D)
29/100
Momentum
5
FBRXValue
41
FBRXSentiment
69
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs FBRX
FULC is the first peer returned for this comparison set.